HDAC1 and pancreatic neoplasm: In human pancreatic cancers (Table 2), 56% of pancreatic cancers show positive immunehistochemical staining for HDAC1, and the co-expression of HDAC1 and hypoxia-inducible factor-1α (HIF-1α) markedly correlates with poor prognosis [36].